Company news
Euda Health Holdings Limited (NASDAQ:EUDA) news
Euda Health Holdings Limited news releases on 6ix. Latest, Aug 26, 2026: EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore
Press releases & updates
EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore
August 26, 2026
EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products
July 30, 2026
EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies
July 28, 2026
EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
June 1, 2026
EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
June 1, 2026
EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development
April 28, 2026
EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities
April 27, 2026
EUDA Announces Reverse Stock Split of its Ordinary Shares
March 18, 2026
EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant
March 4, 2026
EUDA Health Announces Second Amendment to Streeterville Warrant Agreement
January 15, 2026
EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy Platform
January 13, 2026
EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant Agreement
January 7, 2026
EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital
December 30, 2025
EUDA Health to Launch EUDA Helixé 2.0 in January 2026
December 29, 2025
EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen
December 23, 2025
EUDA Integrates QB Utility Token to Create a Digital Health and Rewards Platform Across Its Healthcare Ecosystem
December 21, 2025
EUDA Plans to Integrate QB Utility Token into Its Healthcare Ecosystem
December 7, 2025
EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement
December 5, 2025
EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock India
October 23, 2025
EUDA Subsidiary CK Health Plus Secures Malaysia Direct Selling License, Strengthening Its Longevity Business Across Asia
October 20, 2025
EUDA Signs Letter of Intent to Potentially Acquire GO POSB
September 10, 2025
EUDA Strategically Expands into T-Cell Immunotherapy – Strengthening Its Stem Cell Therapy Portfolio
September 4, 2025
EUDA Signs Letter of Intent to Potentially Acquire Chemokine Pte Ltd
August 28, 2025
EUDA Expands Wellness Product Portfolio With A Next-Generation Immune Health Supplement
August 26, 2025
EUDA Partners with Authorized Distributor of Guangdong Cell Biotech to Offer Stem Cell Therapies to Customers in Singapore and Malaysia
April 24, 2025
EUDA Holdings and Guangdong Cell Biotech Explore Potential Strategic Partnership to Advance Biotechnology Innovation
December 15, 2024
EUDA Health Holdings Limited Completes Acquisition of CK Health Plus Sdn Bhd, Expanding into Direct Selling Holistic Wellness Products in Southeast Asia
May 7, 2024
EUDA Health Expands into Direct Selling Holistic Wellness Products with Acquisition of CK Health
May 5, 2024
EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market’s Continued Listing Requirements After receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
January 15, 2024
EUDA Health Holdings Limited Has Received Nasdaq Notification Regarding Minimum Market Value Deficiency
January 15, 2024
EUDA Health Holdings Limited Enters into Letter of Intent for Proposed Merger with TheoremRx Inc.
October 4, 2023
EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market’s Continued Listing Requirements
September 21, 2023
EUDA Health Holdings Limited Receives Nasdaq Notification Regarding Non-Compliance with Minimum Bid Price Requirement
August 13, 2023
EUDA Health Holdings Limited Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
August 3, 2023
EUDA Health Holdings Limited Announces Receipt of Nasdaq Listing Delinquency Letter
May 18, 2023
8i Acquisition 2 Corp. and EUDA Health Limited Complete Business Combination
November 16, 2022
8i Acquisition 2 Corp. Announces Approval of Business Combination and Ability of Shareholders to Withdraw Ordinary Shares Tendered for Redemption
November 9, 2022
8i Acquisition 2 Corp. and EUDA Health Limited Announce Amendment to Share Purchase Agreement
June 9, 2022
8i Acquisition 2 Corp. and EUDA Health Limited Announce Extension of Due Diligence Review Period
May 30, 2022
8i Acquisition 2 Corp. to Combine with EUDA Health Limited to Bring a Leading Digital Health Platform Servicing Southeast Asia to the Public Market
April 11, 2022